Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

NCT01692925 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A

Interventions

DRUG: turoctocog alfa
DRUG: turoctocog alfa

Sponsor

Novo Nordisk A/S